• 1
    Ablashi, D. V., Balachandran, N., Josephs, S. F., Hung, C. L., Krueger, G. R., Kramarsky, B., Salahuddin, S. Z. et al., Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 1991. 184: 545552.
  • 2
    Zerr, D. M., Human herpesvirus 6: a clinical update. Herpes 2006. 13: 2024.
  • 3
    Yamanishi, K., Okuno, T., Shiraki, K., Takahashi, M., Kondo, T., Asano, Y. and Kurata, T., Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988. 1: 10651067.
  • 4
    Zerr, D. M., Meier, A. S., Selke, S. S., Frenkel, L. M., Huang, M. L., Wald, A., Rhoads, M. P. et al., A population-based study of primary human herpesvirus 6 infection. N. Engl. J. Med. 2005. 352: 768776.
  • 5
    De Bolle, L., Naesens, L. and De Clercq, E., Update on human herpesvirus 6 biology, clinical features, and therapy. Clin. Microbiol. Rev. 2005. 18: 217245.
  • 6
    Hentrich, M., Oruzio, D., Jager, G., Schlemmer, M., Schleuning, M., Schiel, X., Hiddemann, W. et al., Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br. J. Haematol. 2005. 128: 6672.
  • 7
    Ljungman, P., Wang, F. Z., Clark, D. A., Emery, V. C., Remberger, M., Ringden, O. and Linde, A., High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br. J. Haematol. 2000. 111: 774781.
  • 8
    Zerr, D. M., Corey, L., Kim, H. W., Huang, M. L., Nguy, L. and Boeckh, M., Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin. Infect. Dis. 2005. 40: 932940.
  • 9
    Zerr, D. M., Fann, J. R., Breiger, D., Boeckh, M., Adler, A. L., Xie, H., Delaney, C. et al., HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood 2011. 117: 52435249.
  • 10
    Fotheringham, J., Donati, D., Akhyani, N., Fogdell-Hahn, A., Vortmeyer, A., Heiss, J. D., Williams, E. et al., Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med. 2007. 4: e180.
  • 11
    Moss, P. and Rickinson, A., Cellular immunotherapy for viral infection after HSC transplantation. Nat. Rev. Immunol. 2005. 5: 920.
  • 12
    Cobbold, M., Khan, N., Pourgheysari, B., Tauro, S., McDonald, D., Osman, H., Assenmacher, M. et al., Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. 2005. 202: 379386.
  • 13
    Moosmann, A., Bigalke, I., Tischer, J., Schirrmann, L., Kasten, J., Tippmer, S., Leeping, M. et al., Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood 2010. 115: 29602970.
  • 14
    Rooney, C. M., Smith, C. A., Ng, C. Y., Loftin, S. K., Sixbey, J. W., Gan, Y., Srivastava, D. K., et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998. 92: 15491555.
  • 15
    Nastke, M. D., Becerra, A., Yin, L., Dominguez-Amorocho, O., Gibson, L., Stern, L. J. and Calvo-Calle, J. M., Human CD4+ T cell response to human herpesvirus 6. J. Virol. 2012. 86: 47764792.
  • 16
    Lusso, P., HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. J. Clin. Virol. 2006. 37 Suppl 1: S4S10.
  • 17
    Lusso, P., Markham, P. D., Tschachler, E., di Marzo Veronese, F., Salahuddin, S. Z., Ablashi, D. V., Pahwa, S. et al., In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J. Exp. Med. 1988. 167: 16591670.
  • 18
    Flamand, L., Gosselin, J., Stefanescu, I., Ablashi, D. and Menezes, J., Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 1995. 85: 12631271.
  • 19
    Smith, A., Santoro, F., Di Lullo, G., Dagna, L., Verani, A. and Lusso, P., Selective suppression of IL-12 production by human herpesvirus 6. Blood 2003. 102: 28772884.
  • 20
    Wiesner, M., Zentz, C., Mayr, C., Wimmer, R., Hammerschmidt, W., Zeidler, R. and Moosmann, A., Conditional immortalization of human B cells by CD40 ligation. PLoS ONE 2008. 3: e1464.
  • 21
    Zentz, C., Wiesner, M., Man, S., Frankenberger, B., Wollenberg, B., Hillemanns, P., Zeidler, R. et al., Activated B cells mediate efficient expansion of rare antigen-specific T cells. Hum. Immunol. 2007. 68: 7585.
  • 22
    Takahashi, K., Sonoda, S., Higashi, K., Kondo, T., Takahashi, H., Takahashi, M. and Yamanishi, K., Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J. Virol. 1989. 63: 31613163.
  • 23
    Salahuddin, S. Z., Ablashi, D. V., Markham, P. D., Josephs, S. F., Sturzenegger, S., Kaplan, M., Halligan, G. et al., Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986. 234: 596601.
  • 24
    Yakushijin, Y., Yasukawa, M. and Kobayashi, Y., T-cell immune response to human herpesvirus-6 in healthy adults. Microbiol. Immunol. 1991. 35: 655660.
  • 25
    Yakushijin, Y., Yasukawa, M. and Kobayashi, Y., Establishment and functional characterization of human herpesvirus 6-specific CD4+ human T-cell clones. J. Virol. 1992. 66: 27732779.
  • 26
    Yasukawa, M., Yakushijin, Y., Furukawa, M. and Fujita, S., Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J. Virol. 1993. 67: 62596264.
  • 27
    Einsele, H., Roosnek, E., Rufer, N., Sinzger, C., Riegler, S., Loffler, J., Grigoleit, U. et al., Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002. 99: 39163922.
  • 28
    Tejada-Simon, M. V., Zang, Y. C., Hong, J., Rivera, V. M., Killian, J. M. and Zhang, J. Z., Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J. Virol. 2002. 76: 61476154.
  • 29
    Tejada-Simon, M. V., Zang, Y. C., Hong, J., Rivera, V. M. and Zhang, J. Z., Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann. Neurol. 2003. 53: 189197.
  • 30
    Yamamoto, M., Black, J. B., Stewart, J. A., Lopez, C. and Pellett, P. E., Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J. Clin. Microbiol. 1990. 28: 19571962.
  • 31
    Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N. and Pellett, P. E., Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J. Virol. 1999. 73: 80408052.
  • 32
    Gompels, U. A., Nicholas, J., Lawrence, G., Jones, M., Thomson, B. J., Martin, M. E., Efstathiou, S. et al., The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 1995. 209: 2951.
  • 33
    Sylwester, A. W., Mitchell, B. L., Edgar, J. B., Taormina, C., Pelte, C., Ruchti, F., Sleath, P. R. et al., Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 2005. 202: 673685.
  • 34
    Glosson, N. L. and Hudson, A. W., Human herpesvirus-6A and -6B encode viral immunoevasins that downregulate class I MHC molecules. Virology 2007. 365: 125135.
  • 35
    Manley, T. J., Luy, L., Jones, T., Boeckh, M., Mutimer, H. and Riddell, S. R., Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection. Blood 2004. 104: 10751082.
  • 36
    Sullivan, B. M. and Coscoy, L., Downregulation of the T-cell receptor complex and impairment of T-cell activation by human herpesvirus 6 u24 protein. J. Virol. 2008. 82: 602608.
  • 37
    Kakimoto, M., Hasegawa, A., Fujita, S. and Yasukawa, M., Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection. J. Virol. 2002. 76: 1033810345.
  • 38
    Wang, F. Z., Larsson, K., Linde, A. and Ljungman, P., Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2002. 30: 521526.
  • 39
    Wang, F. Z., Linde, A., Dahl, H. and Ljungman, P., Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplant 1999. 24: 12011206.
  • 40
    Tormo, N., Solano, C., de la Camara, R., Garcia-Noblejas, A., Cardenoso, L., Clari, M. A., Nieto, J. et al., An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant 2010. 16: 653661.
  • 41
    Schub, A., Schuster, I. G., Hammerschmidt, W. and Moosmann, A., CMV-specific TCR-transgenic T cells for immunotherapy. J. Immunol. 2009. 183: 68196830.
  • 42
    Moosmann, A., Khan, N., Cobbold, M., Zentz, C., Delecluse, H. J., Hollweck, G., Hislop, A. D., et al., B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells. Blood 2002. 100: 17551764.
  • 43
    Wiesner, M., Zentz, C., Hammer, M. H., Cobbold, M., Kern, F., Kolb, H. J., Hammerschmidt, W., et al., Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines. Eur. J. Immunol. 2005. 35: 21102121.
  • 44
    Rammensee, H., Bachmann, J., Emmerich, N. P., Bachor, O. A. and Stevanovic, S., SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999. 50: 213219.
  • 45
    Hislop, A. D., Taylor, G. S., Sauce, D. and Rickinson, A. B., Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 2007. 25: 587617.
  • 46
    Milosevic, S., Behrends, U., Adhikary, D. and Mautner, J., Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach. J. Virol. 2006. 80: 10357-10364.